Skip to main content

 Scientific publications

Identification of clinical parameters predictive of one-year survival using two geriatric tools in clinically fit older patients with hematological malignancies: Major impact of cognition.

Authors : Dubruille S, Libert Y, Roos M, Vandenbossche S, Collard A, Meuleman N, Maerevoet M, Etienne AM, Reynaert C, Razavi D, Bron D
Year : 2015
Journal : J Geriatr Oncol
Volume : 24(3)
Pages : 294-301

Isolation and Characterization of Human Mesenchymal Stromal Cell Subpopulations: Comparison of Bone Marrow and Adipose Tissue.

Authors : Busser H, Najar M, Raicevic G, Pieters K, Velez Pombo R, Philippart P, Meuleman N, Bron D, Lagneaux L
Year : 2015
Journal : Stem Cells Dev.
Volume : 24(18)
Pages : 2142-57

Avoiding false positive antigen detection by flow cytometry on blood cell derived microparticles: the importance of an appropriate negative control.

Authors : Crompot E, Van Damme M, Duvillier H, Pieters K, Vermeesch M, Perez-Morga D, Meuleman N, Mineur P, Bron D, Lagneaux L, Stamatopoulos B
Year : 2015
Journal : PLoS One
Volume : 10(5)
Pages : e0127209

Tumour targeting and radiation dose of radioimmunotherapy with (90)Y-rituximab in CD20+ B-cell lymphoma as predicted by (89)Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab.

Authors : Muylle K, Flamen P, Vugts DJ, Guiot T, Ghanem G, Meuleman N, Bourgeois P, Vanderlinden B, van Dongen GA, Everaert H, Vaes M, Bron D
Year : 2015
Journal : Eur J Nucl Med Mol Imaging
Volume : 42(8)
Pages : 1304-14

Opposite prognostic significance of cellular and serum circulating microRNA-150 in Chronic Lymphocytic Leukemia patients.

Authors : Stamatopoulos B, Van Damme M, Crompot E, Dessars B, El Housni H, Mineur P, Meuleman N, Bron D, Lagneaux L
Year : 2015
Journal : Mol. Med.
Volume : 21(1)
Pages : 123-33

Isolation of adipose derived stromal cells without enzymatic treatment: expansion, phenotypical and functional characterization.

Authors : Busser H, De Bruyn C, Urbain F, Najar M, Pieters K, Raicevic G, Meuleman N, Bron D, Lagneaux L
Year : 2014
Journal : Stem Cells Dev.
Volume : 23(19)
Pages : 2390-2400

Global histone deacetylase enzymatic activity is an independent prognostic marker associated with a shorter overall survival in chronic lymphocytic leukemia patients.

Authors : Van Damme M, Crompot E, Meuleman N, Mineur P, Dessars B, El Housni H, Bron D, Lagneaux L, Stamatopoulos B
Year : 2014
Journal : Epigenetics
Volume : 9(10)
Pages : 1374-81

In vivo production of mesenchymal stromal cells after injection of autologous platelet-rich plasma activated by recombinant human soluble tissue factor in the bone marrow of healthy volunteers.

Authors : Philippart P, Meuleman N, Stamatopoulos B, Najar M, Pieters K, De Bruyn C, Bron D, Lagneaux L
Year : 2014
Journal : Tissue Eng Part A
Volume : 20(1-2)
Pages : 160-70

Pulmonary Malignancies” “Pulmonary complications of HIV. Edited by Charles Feldman, Eva Polverino, Julio A. Ramirez. ERS/Monograph 66 (chapt 14)

Authors : Sculier JP, Meuleman N, Meert AP, Berghmans T
Year : 2014
Journal : Book
Volume : chapt 14
Pages : 186-198

Radioembolization of the Spleen: A Revisited Approach for the Treatment of Malignant Lymphomatous Splenomegaly. (epub online 2012)

Authors : Muylle K, Nguyen J, de Wind A, Meuleman N, Delatte P, Vanderlinden B, Roelandts M, Vanderstappen A, Bron D, Flamen P
Year : 2013
Journal : Cardiovasc Intervent Radiol
Volume : 36(4)
Pages : 1155-60

Pitfalls of monoclonal gammopathy.

Authors : Meuleman N
Year : 2013
Journal : Rev Med Brux
Volume : 34(4)
Pages : 335-8

Diagnosis and follow-up of monoclonal gammopathies of undetermined significance; information for referring physicians.

Authors : Caers J, Vekemans MC, Bries G, Beel K, Delrieu V, Deweweire A, Demuynck H, De Prijck B, De Samblanx H, Kentos A, Meuleman N, Mineur P, Offner F, Vande Broek I, Van Droogenbroeck J, Vande Velde A, Wu KL, Delforge M, Schots R, Doyen C
Year : 2013
Journal : Ann. Med.
Volume : 45(5-6)
Pages : 413-22

Pomalidomide plus low dose dexamethasone is active and well tolerated in bortezomib and lenalidomide refractory multiple myeloma: IFM 2009-02.

Authors : Leleu X, Attal M, Arnulf B, Moreau P, Traulle C, Marit G, Mathiot C, Petillon MO, Macro M, Roussel M, Pegourie B, Kolb B, Stoppa AM, Hennache B, Bréchignac S, Meuleman N, Thielemans B, Garderet L, Royer B, Hulin C, Benboubker L, Decaux O, Escoffre-Barbe M, Michallet M, Caillot D, Fermand JP, Avet-Loiseau H, Facon T
Year : 2013
Journal : Blood
Volume : 121(11)
Pages : 1968-75

Evidences of early senescence in multiple myeloma bone marrow mesenchymal stromal cells.

Authors : André T, Meuleman N, Stamatopoulos B, De Bruyn C, Pieters K, Bron D, Lagneaux L
Year : 2013
Journal : PLoS One
Volume : 8(3)
Pages : e59756

HDAC isoenzyme expression is deregulated in chronic lymphocytic leukemia B-cells and has a complex prognostic significance.

Authors : Van Damme M, Crompot E, Meuleman N, Mineur P, Bron D, Lagneaux L, Stamatopoulos B
Year : 2012
Journal : Epigenetics
Volume : 7(12)
Pages : 1403-1412

Inflammation and Toll-like receptor ligation differentially affect the osteogenic potential of human mesenchymal stromal cells depending on their tissue origin.

Authors : Raicevic G, Najar M, Pieters K, De Bruyn C, Meuleman N, Bron D, Toungouz M, Lagneaux L
Year : 2012
Journal : Tissue Eng Part A
Volume : 18(13-14)
Pages : 1410-8

Characterization and functionality of the CD200-CD200R system during mesenchymal stromal cell interactions with T-lymphocytes.

Authors : Najar M, Raicevic G, Jebbawi F, De Bruyn C, Meuleman N, Bron D, Toungouz M, Lagneaux L
Year : 2012
Journal : Immunol. Lett.
Volume : 146(1-2)
Pages : 50-6

Safety and Efficacy of Radioimmunotherapy with 90Yttrium-rituximab in Patients with Relapsed CD20+ B cell Lymphoma: A Feasibility Study

Authors : Vaes M, Bron D, Vugts DJ, Paesmans M, Meuleman N, Ghanem G, Vanderlinden B, Thielemans K, van Dongen GA, Flamen P, Muylle K
Year : 2012
Journal : J Cancer Sci Ther
Volume : 4(12)
Pages : 394-400

AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell -based microenvironment: preclinical evidence for its association with chronic lymphocytic leukemia treatments.

Authors : Stamatopoulos B, Meuleman N, De Bruyn C, Pieters K, Mineur P, Le Roy C, Saint-Georges S, Varin-Blank N, Cymbalista F, Bron D, Lagneaux L
Year : 2012
Journal : Haematologica
Volume : 97(4)
Pages : 608-615

The source of human mesenchymal stromal cells influences their TLR profile as well as their functional properties.

Authors : Raicevic G, Najar M, Stamatopoulos B, De Bruyn C, Meuleman N, Bron D, Toungouz M, Lagneaux L
Year : 2011
Journal : Cell. Immunol.
Volume : 270(2)
Pages : 207-16